Justice

MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - IRTC

Retrieved on: 
Thursday, April 4, 2024
Growth, Arrhythmia, Letter, Patient, SAN, Subpoena duces tecum, News, Pension, Medical device, Medical device reporting, Complaint, Justice, Food, Marketing, FDA, IRTC

Lead plaintiff motions for the iRhythm class action lawsuit must be filed with the court no later than April 8, 2024.

Key Points: 
  • Lead plaintiff motions for the iRhythm class action lawsuit must be filed with the court no later than April 8, 2024.
  • A lead plaintiff acts on behalf of all other class members in directing the iRhythm class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the iRhythm class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the iRhythm class action lawsuit.

Alamos Gold Announces Closing of Orford Mining Acquisition

Retrieved on: 
Wednesday, April 3, 2024
AGI, Acquisition, TSX, Justice, Transaction

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today reported the completion of the previously announced acquisition (the “Transaction”) of all the issued and outstanding common shares of Orford Mining Corporation (TSXV:ORM) (“Orford Mining”).

Key Points: 
  • TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) today reported the completion of the previously announced acquisition (the “Transaction”) of all the issued and outstanding common shares of Orford Mining Corporation (TSXV:ORM) (“Orford Mining”).
  • A Final Order was granted by the Ontario Superior Court of Justice on April 2, 2024 approving the Plan of Arrangement pursuant to which the Transaction was implemented.
  • “We are pleased to complete the acquisition of Orford Mining and its highly prospective Qiqavik Gold Project, located in Northern Quebec.
  • The acquisition is consistent with our strategy of building out a pipeline of high-quality, long-term projects, in good jurisdictions to complement our near-term organic growth projects in Canada,” said John A. McCluskey, President and Chief Executive Officer.

Illegal Surveillance In Americans Homes & Devices Immediate Oversight Of Clearview AI & Similar Technologies Demanded By The McWhorter Foundation

Retrieved on: 
Wednesday, April 3, 2024
Freedom, Private, Trust, Internet of things, PALM, CK, Fourth Amendment, Law enforcement, Internet, Clearview AI, Impact, Privacy, Computer, Motorola Solutions, Weapon, Economic methodology, Data collection, Justice, Supreme court, Community engagement, Safety, Habit, Brennan Center for Justice, Family, Facial recognition

These technologies can capture detailed and intimate information about our private lives​ ( Brookings )​​ ( Brennan Center for Justice )​.

Key Points: 
  • These technologies can capture detailed and intimate information about our private lives​ ( Brookings )​​ ( Brennan Center for Justice )​.
  • The use of surveillance technology, including data monitoring and facial recognition, by law enforcement has significantly expanded, raising important questions about privacy, especially within private settings.
  • Independent Oversight and Regulation: We demand the establishment of rigorous oversight mechanisms, including independent bodies that involve community representatives to oversee the deployment and use of surveillance technologies.
  • McWhorter Foundation has not registered with the U.S. Securities and Exchange Commission (SEC) and may operate under exemptions.

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

Retrieved on: 
Wednesday, April 3, 2024
Zio, Advertising, Boston Scientific, J. P. Morgan, Growth, Patient, Subpoena duces tecum, LLP, DOJ, Justice, Marketing, FDA, Court, IRTC, Pharmaceutical industry

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding iRhythm’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Retiree Shareowners at Verizon Push Clawback Policy & Transparency on Lead Cables Hazard

Retrieved on: 
Tuesday, April 2, 2024
Risk, Public, SPRING, Policy, Item, Justice, VZ, The Wall Street Journal, Cryptocurrency

have two shareholder proposals that will be voted on at the 2024 Verizon ( NYSE: VZ ) annual shareowner meeting taking place on May 9, 2024 .

Key Points: 
  • have two shareholder proposals that will be voted on at the 2024 Verizon ( NYSE: VZ ) annual shareowner meeting taking place on May 9, 2024 .
  • The first centers on the senior executive clawback policy and the second targets lead cables.
  • The BellTel Retirees have a long track record of acting as an integral check for better governance practices .
  • The first retiree proposal, which gained 37.9% of the vote in 2023, proposes to amend Verizon’s Senior Executive Compensation Clawback Policy ( Item #6 ).

iRhythm Technologies, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; April 8, 2024 deadline

Retrieved on: 
Monday, April 1, 2024
Letter, Disclosure, Justice, Lung compliance, Marketing, FDA, IRTC, Pharmaceutical industry

​LOS ANGELES, April 01, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises iRhythm Technologies, Inc. (NASDAQ: IRTC) investors that a lawsuit was filed on behalf of investors that purchased iRhythm securities between January 11, 2022 and May 30, 2023, 2023, inclusive (the “Class Period”).

Key Points: 
  • ​LOS ANGELES, April 01, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises iRhythm Technologies, Inc. (NASDAQ: IRTC) investors that a lawsuit was filed on behalf of investors that purchased iRhythm securities between January 11, 2022 and May 30, 2023, 2023, inclusive (the “Class Period”).
  • Investors are encouraged to contact attorney Lesley F. Portnoy , by phone 310-692-8883 or email : [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com .
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing.

Inari Medical, Inc. (NARI) Plummets on News of DOJ Investigation – Hagens Berman

Retrieved on: 
Monday, April 1, 2024
NARI, Medicine, Health, Piper Sandler Companies, News, Person, Disclosure, DOJ, Justice, Hagens Berman, Pharmaceutical industry

Inari Medical shares recently tumbled after the commercial-stage medical device company disclosed it was being investigated by the DOJ over certain payments to healthcare professionals.

Key Points: 
  • Inari Medical shares recently tumbled after the commercial-stage medical device company disclosed it was being investigated by the DOJ over certain payments to healthcare professionals.
  • But on Feb. 29, 2024, the true drivers of Inari’s revenue growth came into question, when Inari revealed that federal regulators had initiated an investigation into its payments to Health Care Professionals (“HCPs”) sometime during Dec. 2023.
  • This news sent the price of Inari shares crashing $12.14, or down about 21%, on Feb. 29, 2024.
  • “We are investigating the propriety of Inari’s touted revenue growth and repeated claims that its strategy had positioned it for sustained operating profitability by the first half of 2025,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - IRTC

Retrieved on: 
Monday, April 1, 2024
Growth, Arrhythmia, Letter, Patient, SAN, Subpoena duces tecum, News, Pension, Medical device, Medical device reporting, Complaint, Justice, Food, Marketing, FDA, IRTC

Lead plaintiff motions for the iRhythm class action lawsuit must be filed with the court no later than April 8, 2024.

Key Points: 
  • Lead plaintiff motions for the iRhythm class action lawsuit must be filed with the court no later than April 8, 2024.
  • A lead plaintiff acts on behalf of all other class members in directing the iRhythm class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the iRhythm class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the iRhythm class action lawsuit.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inari Medical, Inc. (NARI) Investors with Substantial Losses to Contact Firm, NARI Plummets on News of DOJ Investigation – Hagens Berman

Retrieved on: 
Thursday, March 28, 2024
NARI, Health, Piper Sandler Companies, SAN, News, Person, Disclosure, DOJ, Justice, Hagens Berman, Pharmaceutical industry

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now .
  • Inari Medical shares recently tumbled after the commercial-stage medical device company disclosed it was being investigated by the DOJ over certain payments to healthcare professionals.
  • This news sent the price of Inari shares crashing $12.14, or down about 21%, on Feb. 29, 2024.
  • Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

Retrieved on: 
Thursday, March 28, 2024
Zio, Advertising, Boston Scientific, J. P. Morgan, Growth, Patient, Subpoena duces tecum, LLP, DOJ, Justice, Marketing, FDA, Court, IRTC, Pharmaceutical industry

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the Class Period.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding iRhythm’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.